Health Canada actions
This article was originally published in The Tan Sheet
Executive Summary
Agency warns consumers not to use seven herbal products manufactured by BotanicLab due to contamination with Rx drugs indomethicin, diethylstilbestrol, alprazolam, according to June 19 warning. Affected products include Arthrin, Hepastat, RA Spes capsules, which are sold by mail, phone, Internet. BotanicLab recently ceased operations after its PC-SPES herbal blend was recalled for similar reasons (1"The Tan Sheet" June 3, 2002, p. 5). In separate June 14 advisory, Health Canada cautions against use of Bejai Bowyantan, a traditional Chinese medicine for infants, due to presence of 5% borneolum syntheticum, which has a similar toxicity profile to camphor, agency says...
You may also be interested in...
BotanicLab Intentional Rx Lacing Alleged In Amended Lawsuit
An amended class action complaint against PC-SPES marketer BotanicLab alleges company representatives intentionally mixed the Rx ingredients alprazolam, indomethacin and diethylstilbestrol (DES) into seven other dietary supplement products
Future NCCAM Botanical Study Standards To Reflect PC-SPES Lessons
The NIH National Center for Complementary & Alternative Medicine is expected to impose stricter standards on products used in research it funds in light of the PC-SPES contamination problems
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.